Rani Therapeutics Holdings Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -17.8% | -7.6% | -18.3% | -0.4% | -15.9% | -34.1% | -30.0% | -40.0% | +478.2% | -11.5% | +17.3% | |
| – | -19.6% | -18.6% | -22.6% | +1.1% | -8.1% | -40.2% | -37.7% | -55.3% | +976.1% | -11.7% | +20.0% | |
| – | +17.9% | +17.3% | -34.4% | -5.3% | -12.0% | +168.8% | +1.0% | -59.4% | +349.3% | -48.2% | -49.5% | |
| – | -19.8% | -18.5% | -21.9% | -1.6% | -9.1% | -42.6% | -35.6% | -59.4% | +1,099.5% | -12.7% | +23.0% | |
| – | +0.0% | +0.0% | -50.0% | +100.0% | +114.0% | +40.2% | -97.0% | – | – | +3.5% | +4.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -8.8% | +20.0% | -2.1% | -1.1% | -12.2% | -11.1% | -11.6% | -15.1% | -22.6% | -4.5% | -21.3% | |
| – | +8.8% | +67.4% | +24.0% | +21.9% | -1.6% | +1.2% | +2.4% | -7.2% | -33.8% | +9.4% | -23.2% | |
| – | +179.4% | +74.7% | +39.2% | +18.5% | +1.7% | -0.8% | -0.8% | -9.9% | -89.1% | -7.9% | -9.0% | |
| – | -53.9% | +24.4% | -37.2% | +209.5% | -13.2% | +11.8% | +18.3% | +37.2% | -87.5% | +177.7% | +22.3% | |
| – | -12.9% | -14.8% | -17.5% | -21.3% | -29.0% | -38.4% | -62.4% | – | – | – | – | |
| – | -26.7% | -42.5% | -61.7% | +10.1% | -36.2% | -253.4% | – | – | – | -14.0% | +38.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.3% | +0.6% | +1.1% | +9.5% | +13.3% | +2.4% | +9.3% | +0.0% | +302.5% | +22.4% | +4.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.